{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T12:19:20Z","timestamp":1773058760343,"version":"3.50.1"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Asian Journal of Psychiatry"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.ajp.2024.103992","type":"journal-article","created":{"date-parts":[[2024,3,4]],"date-time":"2024-03-04T02:52:14Z","timestamp":1709520734000},"page":"103992","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["A case report of LAI two injection start in a 16-year-old adolescent with severe manic episode and comorbid cannabinoid use disorder"],"prefix":"10.1016","volume":"94","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6882-3770","authenticated-orcid":false,"given":"Laura","family":"Orsolini","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sofia Pacini","family":"Biagiotti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lorenzo Maria","family":"Martino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Umberto","family":"Volpe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.ajp.2024.103992_bib1","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s40272-023-00558-x","article-title":"What role for long-acting injectable antipsychotics in managing schizophrenia spectrum disorders in children and adolescents? A systematic review","volume":"25","author":"Baeza","year":"2023","journal-title":"Paediatr. Drugs"},{"key":"10.1016\/j.ajp.2024.103992_bib2","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1192\/bjp.154.5.672","article-title":"A rating scale for drug-induced akathisia","volume":"154","author":"Barnes","year":"1989","journal-title":"BJP"},{"issue":"9","key":"10.1016\/j.ajp.2024.103992_bib3","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1007\/s40263-016-0367-y","article-title":"Aripiprazole and acute extrapyramidal symptoms in children and adolescents: a meta-analysis","volume":"30","author":"Bernagie","year":"2016","journal-title":"CNS Drugs"},{"issue":"1","key":"10.1016\/j.ajp.2024.103992_bib4","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s40263-020-00779-5","article-title":"Pharmacokinetic characteristics of long-acting injectable antipsychotics for schizophrenia: an overview","volume":"35","author":"Correll","year":"2021","journal-title":"CNS Drugs"},{"issue":"1","key":"10.1016\/j.ajp.2024.103992_bib5","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1097\/JCP.0000000000001629","article-title":"Two-Injection Start Regimen of Long-Acting Aripiprazole in 133 Patients With Schizophrenia","volume":"43","author":"Cuomo","year":"2023","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.ajp.2024.103992_bib6","unstructured":"Gettu N., Saadabadi A.. Aripiprazole. 2023 May 16. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023 Jan\u2013. PMID: 31613519."},{"issue":"2-3","key":"10.1016\/j.ajp.2024.103992_bib7","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.schres.2005.03.008","article-title":"Abnormal Involuntary Movement Scale (AIMS) and Extrapyramidal Symptom Rating Scale (ESRS): cross-scale comparison in assessing tardive dyskinesia","volume":"77","author":"Gharabawi","year":"2005","journal-title":"Schizophr. Res"},{"key":"10.1016\/j.ajp.2024.103992_bib8","unstructured":"Guy W. Clinical Global Impressions (CGI) Scale, Modified. In Rush, John A.; Task Force for the Handbook of Psychiatric Measures (eds.). Handbook of Psychiatric Measures (1st ed.). Washington, DC: American Psychiatric Association. 2000."},{"issue":"5","key":"10.1016\/j.ajp.2024.103992_bib9","doi-asserted-by":"crossref","first-page":"617","DOI":"10.4088\/JCP.11m07530","article-title":"Aripiprazole intramuscular depot as maintenance treatment in patients with schizophrenia: a 52-week, multicenter, randomized, double-blind, placebo-controlled study","volume":"73","author":"Kane","year":"2012","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.ajp.2024.103992_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajp.2023.103671","article-title":"Clinical benefit of second-generation long-acting injectable antipsychotics in preventing re-hospitalization in patients with schizophrenia: A real-world study in Japan","volume":"86","author":"Kasahara-Kiritani","year":"2023","journal-title":"Asian J. Psychiatr."},{"issue":"2","key":"10.1016\/j.ajp.2024.103992_bib11","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/schbul\/13.2.261","article-title":"The positive and negative syndrome scale (PANSS) for schizophrenia","volume":"13","author":"Kay","year":"1987","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.ajp.2024.103992_bib12","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/j.jaac.2013.02.008","article-title":"Practice parameter for the assessment and treatment of children and adolescents with schizophrenia","volume":"52","author":"McClellan","year":"2013","journal-title":"J. Am. Acad. Child Adolesc. Psychiatry"},{"key":"10.1016\/j.ajp.2024.103992_bib13","unstructured":"National Institute for Health and Care Excellence (NICE). Psychosis and schizophrenia in adults: prevention and management. London: 2014."},{"issue":"1","key":"10.1016\/j.ajp.2024.103992_bib14","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1186\/s12888-023-04893-8","article-title":"Improvement of functioning in patients with schizophrenia: real-world effectiveness of aripiprazole once-monthly (REACT study)","volume":"23","author":"Oluboka","year":"2023","journal-title":"BMC Psychiatry"},{"issue":"10","key":"10.1016\/j.ajp.2024.103992_bib15","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1080\/14740338.2016.1201475","article-title":"An update of safety of clinically used atypical antipsychotics","volume":"15","author":"Orsolini","year":"2016","journal-title":"Expert Opin. Drug Saf."},{"issue":"3","key":"10.1016\/j.ajp.2024.103992_bib16","doi-asserted-by":"crossref","first-page":"799","DOI":"10.2466\/pr0.1962.10.3.799","article-title":"The brief psychiatric rating scale","volume":"10","author":"Overall","year":"1962","journal-title":"Psychol. Rep."},{"issue":"4","key":"10.1016\/j.ajp.2024.103992_bib17","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.euroneuro.2019.02.003","article-title":"Long-acting injectable antipsychotics (LAIs) for maintenance treatment of bipolar and schizoaffective disorders: a systematic review","volume":"29","author":"Pacchiarotti","year":"2019","journal-title":"Eur. Neuropsychopharmacol."},{"issue":"4","key":"10.1016\/j.ajp.2024.103992_bib18","doi-asserted-by":"crossref","first-page":"454","DOI":"10.2174\/1871527316666170223163629","article-title":"Suicide prevention in schizophrenia: do long-acting injectable antipsychotics (LAIs) have a role?","volume":"16","author":"Pompili","year":"2017","journal-title":"CNS Neurol. Disord. Drug Targets"},{"issue":"8","key":"10.1016\/j.ajp.2024.103992_bib19","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1007\/s40261-019-00801-9","article-title":"Long-acting injectable (LAI) aripiprazole formulations in the treatment of schizophrenia and bipolar disorder: a systematic review","volume":"39","author":"Rapinesi","year":"2019","journal-title":"Clin. Drug Invest."},{"key":"10.1016\/j.ajp.2024.103992_bib20","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.jclinepi.2017.04.026","article-title":"CARE guidelines for case reports: explanation and elaboration document","volume":"89","author":"Riley","year":"2017","journal-title":"J. Clin. Epidemiol."},{"issue":"2","key":"10.1016\/j.ajp.2024.103992_bib21","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1002\/npr2.12240","article-title":"Aripiprazole LAI two-injection start in a 16 year-old adolescent with schizophrenia","volume":"42","author":"Salvi","year":"2022","journal-title":"Neuropsychopharmacol. Rep."},{"issue":"11","key":"10.1016\/j.ajp.2024.103992_bib22","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1080\/03007995.2021.1965974","article-title":"An alternative start regimen with aripiprazole once-monthly in patients with schizophrenia: population pharmacokinetic analysis of a single-day, two-injection start with gluteal and\/or deltoid intramuscular injection","volume":"37","author":"Wang","year":"2021","journal-title":"Curr. Med Res Opin."},{"issue":"1","key":"10.1016\/j.ajp.2024.103992_bib23","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1080\/03007995.2017.1395733","article-title":"All-cause hospitalization and associated costs in patients with schizophrenia or bipolar disorder initiating long-acting injectable antipsychotics","volume":"34","author":"Yan","year":"2018","journal-title":"Curr. Med Res Opin."},{"issue":"11","key":"10.1016\/j.ajp.2024.103992_bib24","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.2217\/cer-2018-0068","article-title":"Impact of initiating long-acting injectable antipsychotics on hospitalization in patients with bipolar I disorder","volume":"7","author":"Yan","year":"2018","journal-title":"J. Comp. Eff. Res"},{"key":"10.1016\/j.ajp.2024.103992_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajp.2023.103789","article-title":"Comparison of health resource usage and costs associated with first-generation and second-generation long-acting injectable antipsychotics for patients with schizophrenia: A nationwide population-based cohort study","volume":"89","author":"Yang","year":"2023","journal-title":"Asian J. Psychiatr."},{"key":"10.1016\/j.ajp.2024.103992_bib26","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1192\/bjp.133.5.429","article-title":"A rating scale for mania: reliability, validity and sensitivity","volume":"133","author":"Young","year":"1978","journal-title":"Br. J. Psychiatry"}],"container-title":["Asian Journal of Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1876201824000856?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1876201824000856?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T16:53:39Z","timestamp":1761756819000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1876201824000856"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":26,"alternative-id":["S1876201824000856"],"URL":"https:\/\/doi.org\/10.1016\/j.ajp.2024.103992","relation":{},"ISSN":["1876-2018"],"issn-type":[{"value":"1876-2018","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A case report of LAI two injection start in a 16-year-old adolescent with severe manic episode and comorbid cannabinoid use disorder","name":"articletitle","label":"Article Title"},{"value":"Asian Journal of Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajp.2024.103992","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"103992"}}